CNS demyelinating disease following inactivated or viral vector SARS-CoV-2 vaccines: A case series

CONCLUSION: Our case series identifies the Sinopharm BBIBP-CorV and the AstraZeneca AZD1222 vaccines as potential triggers for CNS demyelinating diseases. Vaccine administration routines are not affected by these rare and coincidental events. However, these manifestations are not deniable and require serious attention. Further investigations are needed to clarify the actual mechanisms and real associations.PMID:36635139 | PMC:PMC9816077 | DOI:10.1016/j.vaccine.2023.01.003

Source: Vaccine - January 12, 2023 Category: Allergy & Immunology Authors: Narges Ebrahimi Mahsa Mazdak Vahid Shaygannejad Omid Mirmosayyeb Source Type: research